1,933
Views
13
CrossRef citations to date
0
Altmetric
Research Paper

Increased oxidative stress, inflammation and fibrosis in perirenal adipose tissue of patients with cortisol-producing adenoma

, , , , , , , ORCID Icon, , , & show all
Pages 347-356 | Received 06 Jul 2019, Accepted 02 Nov 2019, Published online: 13 Nov 2019

References

  • Arnaldi G, Angeli A, Atkinson AB, et al. Diagnosis and complications of Cushing’s syndrome: a consensus statement. J Clin Endocrinol Metab. 2003;88:5593–5602.
  • Nieman LK. Diagnosis of Cushing’s syndrome in the modern era. Endocrinol Metab Clin North Am. 2018;47:259–273.
  • Dekkers OM, Horvath-Puho E, Jorgensen JO, et al. Multisystem morbidity and mortality in Cushing’s syndrome: a cohort study. J Clin Endocrinol Metab. 2013;98:2277–2284.
  • Lee IT, Atuahene A, Egritag HE, et al. Active Cushing’s disease is characterized by increased adipose tissue macrophage presence. J Clin Endocrinol Metab. 2019;104:2453–2461.
  • Svensson PA, Lindberg K, Hoffmann JM, et al. Characterization of brown adipose tissue in the human perirenal depot. Obesity (Silver Spring, Md). 2014;22:1830–1837.
  • Wu C, Zhang H, Zhang J, et al. Inflammation and fibrosis in perirenal adipose tissue of patients with aldosterone-producing adenoma. Endocrinology. 2018;159:227–237.
  • Crewe C, An YA, Scherer PE. The ominous triad of adipose tissue dysfunction: inflammation, fibrosis, and impaired angiogenesis. J Clin Invest. 2017;127:74–82.
  • Nieman LK, Biller BM, Findling JW, et al. The diagnosis of Cushing’s syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008;93:1526–1540.
  • Wang D, Guan MP, Zheng ZJ, et al. Transcription factor Egr1 is involved in high glucose-induced proliferation and fibrosis in rat glomerular mesangial cells. Cell Physiol Biochem. 2015;36:2093–2107.
  • Zeng Y, Li C, Guan M, et al. The DPP-4 inhibitor sitagliptin attenuates the progress of atherosclerosis in apolipoprotein-E-knockout mice via AMPK- and MAPK-dependent mechanisms. Cardiovasc Diabetol. 2014;13:32.
  • Fasshauer M, Klein J, Kriauciunas KM, et al. Essential role of insulin receptor substrate 1 in differentiation of brown adipocytes. Mol Cell Biol. 2001;21:319–329.
  • Klein J, Fasshauer M, Ito M, et al. beta(3)-adrenergic stimulation differentially inhibits insulin signaling and decreases insulin-induced glucose uptake in brown adipocytes. J Biol Chem. 1999;274:34795–34802.
  • Cypess AM, White AP, Vernochet C, et al. Anatomical localization, gene expression profiling and functional characterization of adult human neck brown fat. Nat Med. 2013;19:635–639.
  • Fuster JJ, Ouchi N, Gokce N, et al. Obesity-induced changes in adipose tissue microenvironment and their impact on cardiovascular disease. Circ Res. 2016;118:1786–1807.
  • Haemers P, Hamdi H, Guedj K, et al. Atrial fibrillation is associated with the fibrotic remodelling of adipose tissue in the subepicardium of human and sheep atria. Eur Heart J. 2017;38:53–61.
  • Patsouris D, Neels JG, Fan W, et al. Glucocorticoids and thiazolidinediones interfere with adipocyte-mediated macrophage chemotaxis and recruitment. J Biol Chem. 2009;284:31223–31235.
  • Aulinas A, Ramirez MJ, Barahona MJ, et al. Dyslipidemia and chronic inflammation markers are correlated with telomere length shortening in Cushing’s syndrome. PloS One. 2015;10:e0120185.
  • Barahona MJ, Sucunza N, Resmini E, et al. Persistent body fat mass and inflammatory marker increases after long-term cure of Cushing’s syndrome. J Clin Endocrinol Metab. 2009;94:3365–3371.
  • Barber AE, Coyle SM, Marano MA, et al. Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man. J Immunol. 1993;150:1999–2006.
  • Hochberg I, Harvey I, Tran QT, et al. Gene expression changes in subcutaneous adipose tissue due to Cushing’s disease. J Mol Endocrinol. 2015;55:81–94.
  • Roerink S, Wagenmakers M, Langenhuijsen JF, et al. Increased adipocyte size, macrophage infiltration, and adverse local adipokine profile in perirenal fat in Cushing’s syndrome. Obesity (Silver Spring, Md). 2017;25:1369–1374.
  • Henegar C, Tordjman J, Achard V, et al. Adipose tissue transcriptomic signature highlights the pathological relevance of extracellular matrix in human obesity. Genome Biol. 2008;9:R14.
  • Sun K, Tordjman J, Clement K, et al. Fibrosis and adipose tissue dysfunction. Cell Metab. 2013;18:470–477.
  • Rizzoni D, Porteri E, De Ciuceis C, et al. Hypertrophic remodeling of subcutaneous small resistance arteries in patients with Cushing’s syndrome. J Clin Endocrinol Metab. 2009;94:5010–5018.
  • Houstis N, Rosen ED, Lander ES. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature. 2006;440:944–948.
  • Wagenmakers M, Roerink S, Gil L, et al. Persistent centripetal fat distribution and metabolic abnormalities in patients in long-term remission of Cushing’s syndrome. Clin Endocrinol (Oxf). 2015;82:180–187.
  • Karamouzis I, Berardelli R, D’Angelo V, et al. Enhanced oxidative stress and platelet activation in patients with Cushing’s syndrome. Clin Endocrinol (Oxf). 2015;82:517–524.
  • Kolattukudy PE, Niu J. Inflammation, endoplasmic reticulum stress, autophagy, and the monocyte chemoattractant protein-1/CCR2 pathway. Circ Res. 2012;110:174–189.